<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">34205102</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>26</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>26</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2073-4409</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>10</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Jun</Month>
              <Day>03</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cells</Title>
          <ISOAbbreviation>Cells</ISOAbbreviation>
        </Journal>
        <ArticleTitle>TGF-β/Smad Signalling in Neurogenesis: Implications for Neuropsychiatric Diseases.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">1382</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/cells10061382</ELocationID>
        <Abstract>
          <AbstractText>TGF-β/Smad signalling has been the subject of extensive research due to its role in the cell cycle and carcinogenesis. Modifications to the TGF-β/Smad signalling pathway have been found to produce disparate effects on neurogenesis. We review the current research on canonical and non-canonical TGF-β/Smad signalling pathways and their functions in neurogenesis. We also examine the observed role of neurogenesis in neuropsychiatric disorders and the relationship between TGF-β/Smad signalling and neurogenesis in response to stressors. Overlapping mechanisms of cell proliferation, neurogenesis, and the development of mood disorders in response to stressors suggest that TGF-β/Smad signalling is an important regulator of stress response and is implicated in the behavioural outcomes of mood disorders.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hiew</LastName>
            <ForeName>Lih-Fhung</ForeName>
            <Initials>LF</Initials>
            <AffiliationInfo>
              <Affiliation>Neuromodulation Laboratory, School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Poon</LastName>
            <ForeName>Chi-Him</ForeName>
            <Initials>CH</Initials>
            <Identifier Source="ORCID">0000-0001-7275-0351</Identifier>
            <AffiliationInfo>
              <Affiliation>Neuromodulation Laboratory, School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>You</LastName>
            <ForeName>Heng-Ze</ForeName>
            <Initials>HZ</Initials>
            <AffiliationInfo>
              <Affiliation>Neuromodulation Laboratory, School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lim</LastName>
            <ForeName>Lee-Wei</ForeName>
            <Initials>LW</Initials>
            <Identifier Source="ORCID">0000-0001-6692-6285</Identifier>
            <AffiliationInfo>
              <Affiliation>Neuromodulation Laboratory, School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>06</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Cells</MedlineTA>
        <NlmUniqueID>101600052</NlmUniqueID>
        <ISSNLinking>2073-4409</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051785">Smad Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016212">Transforming Growth Factor beta</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019964" MajorTopicYN="N">Mood Disorders</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009422" MajorTopicYN="N">Nervous System Diseases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051785" MajorTopicYN="N">Smad Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016212" MajorTopicYN="N">Transforming Growth Factor beta</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">TGF-β</Keyword>
        <Keyword MajorTopicYN="Y">depression</Keyword>
        <Keyword MajorTopicYN="Y">neurogenesis</Keyword>
        <Keyword MajorTopicYN="Y">smad</Keyword>
        <Keyword MajorTopicYN="Y">stress</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>2</Day>
          <Hour>1</Hour>
          <Minute>23</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34205102</ArticleId>
        <ArticleId IdType="pmc">PMC8226492</ArticleId>
        <ArticleId IdType="doi">10.3390/cells10061382</ArticleId>
        <ArticleId IdType="pii">cells10061382</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Derynck R., Akhurst R.J. Differentiation plasticity regulated by TGF-beta family proteins in development and disease. Nat. Cell Biol. 2007;9:1000–1004. doi: 10.1038/ncb434.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncb434</ArticleId>
            <ArticleId IdType="pubmed">17762890</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Massague J., Blain S.W., Lo R.S. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell. 2000;103:295–309. doi: 10.1016/S0092-8674(00)00121-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0092-8674(00)00121-5</ArticleId>
            <ArticleId IdType="pubmed">11057902</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ten Dijke P., Hill C.S. New insights into TGF-beta-Smad signalling. Trends Biochem. Sci. 2004;29:265–273. doi: 10.1016/j.tibs.2004.03.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tibs.2004.03.008</ArticleId>
            <ArticleId IdType="pubmed">15130563</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakao A., Afrakhte M., Moren A., Nakayama T., Christian J.L., Heuchel R., Itoh S., Kawabata M., Heldin N.E., Heldin C.H., et al.  Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature. 1997;389:631–635. doi: 10.1038/39369.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/39369</ArticleId>
            <ArticleId IdType="pubmed">9335507</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Derynck R., Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003;425:577–584. doi: 10.1038/nature02006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature02006</ArticleId>
            <ArticleId IdType="pubmed">14534577</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Massague J. TGFbeta in Cancer. Cell. 2008;134:215–230. doi: 10.1016/j.cell.2008.07.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2008.07.001</ArticleId>
            <ArticleId IdType="pmc">PMC3512574</ArticleId>
            <ArticleId IdType="pubmed">18662538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lyons R.M., Moses H.L. Transforming growth factors and the regulation of cell proliferation. Eur. J. Biochem. 1990;187:467–473. doi: 10.1111/j.1432-1033.1990.tb15327.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1432-1033.1990.tb15327.x</ArticleId>
            <ArticleId IdType="pubmed">2406131</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vogel T., Ahrens S., Buttner N., Krieglstein K. Transforming growth factor beta promotes neuronal cell fate of mouse cortical and hippocampal progenitors in vitro and in vivo: Identification of Nedd9 as an essential signaling component. Cereb. Cortex. 2010;20:661–671. doi: 10.1093/cercor/bhp134.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cercor/bhp134</ArticleId>
            <ArticleId IdType="pmc">PMC2820705</ArticleId>
            <ArticleId IdType="pubmed">19587023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wachs F.P., Winner B., Couillard-Despres S., Schiller T., Aigner R., Winkler J., Bogdahn U., Aigner L. Transforming growth factor-beta1 is a negative modulator of adult neurogenesis. J. Neuropathol. Exp. Neurol. 2006;65:358–370. doi: 10.1097/01.jnen.0000218444.53405.f0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.jnen.0000218444.53405.f0</ArticleId>
            <ArticleId IdType="pubmed">16691117</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abe K., Chu P.J., Ishihara A., Saito H. Transforming growth factor-beta 1 promotes re-elongation of injured axons of cultured rat hippocampal neurons. Brain Res. 1996;723:206–209. doi: 10.1016/0006-8993(96)00253-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0006-8993(96)00253-3</ArticleId>
            <ArticleId IdType="pubmed">8813400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Knoferle J., Ramljak S., Koch J.C., Tonges L., Asif A.R., Michel U., Wouters F.S., Heermann S., Krieglstein K., Zerr I., et al.  TGF-beta 1 enhances neurite outgrowth via regulation of proteasome function and EFABP. Neurobiol. Dis. 2010;38:395–404. doi: 10.1016/j.nbd.2010.02.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.nbd.2010.02.011</ArticleId>
            <ArticleId IdType="pubmed">20211260</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yi J.J., Barnes A.P., Hand R., Polleux F., Ehlers M.D. TGF-beta signaling specifies axons during brain development. Cell. 2010;142:144–157. doi: 10.1016/j.cell.2010.06.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2010.06.010</ArticleId>
            <ArticleId IdType="pmc">PMC2933408</ArticleId>
            <ArticleId IdType="pubmed">20603020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beauregard M., Levesque J., Bourgouin P. Neural correlates of conscious self-regulation of emotion. J. Neurosci. 2001;21:RC165. doi: 10.1523/JNEUROSCI.21-18-j0001.2001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.21-18-j0001.2001</ArticleId>
            <ArticleId IdType="pmc">PMC6763007</ArticleId>
            <ArticleId IdType="pubmed">11549754</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patten S.B. Sensitization: The sine qua non of the depressive disorders? Med. Hypotheses. 2008;71:872–875. doi: 10.1016/j.mehy.2008.06.040.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mehy.2008.06.040</ArticleId>
            <ArticleId IdType="pubmed">18768266</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ekdahl C.T., Claasen J.H., Bonde S., Kokaia Z., Lindvall O. Inflammation is detrimental for neurogenesis in adult brain. Proc. Natl. Acad. Sci. USA. 2003;100:13632–13637. doi: 10.1073/pnas.2234031100.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.2234031100</ArticleId>
            <ArticleId IdType="pmc">PMC263865</ArticleId>
            <ArticleId IdType="pubmed">14581618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang B., Jin K. Current perspectives on the link between neuroinflammation and neurogenesis. Metab. Brain Dis. 2015;30:355–365. doi: 10.1007/s11011-014-9523-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11011-014-9523-6</ArticleId>
            <ArticleId IdType="pubmed">24623361</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garcia-Bueno B., Caso J.R., Leza J.C. Stress as a neuroinflammatory condition in brain: Damaging and protective mechanisms. Neurosci. Biobehav. Rev. 2008;32:1136–1151. doi: 10.1016/j.neubiorev.2008.04.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neubiorev.2008.04.001</ArticleId>
            <ArticleId IdType="pubmed">18468686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Menachem-Zidon O.B., Goshen I., Kreisel T., Menahem Y.B., Reinhartz E., Hur T.B., Yirmiya R. Intrahippocampal transplantation of transgenic neural precursor cells overexpressing interleukin-1 receptor antagonist blocks chronic isolation-induced impairment in memory and neurogenesis. Neuropsychopharmacology. 2008;33:2251–2262. doi: 10.1038/sj.npp.1301606.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.npp.1301606</ArticleId>
            <ArticleId IdType="pubmed">17987063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goshen I., Kreisel T., Ben-Menachem-Zidon O., Licht T., Weidenfeld J., Ben-Hur T., Yirmiya R. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol. Psychiatry. 2008;13:717–728. doi: 10.1038/sj.mp.4002055.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.mp.4002055</ArticleId>
            <ArticleId IdType="pubmed">17700577</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dias J.M., Alekseenko Z., Applequist J.M., Ericson J. Tgfbeta signaling regulates temporal neurogenesis and potency of neural stem cells in the CNS. Neuron. 2014;84:927–939. doi: 10.1016/j.neuron.2014.10.033.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuron.2014.10.033</ArticleId>
            <ArticleId IdType="pubmed">25467979</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kandasamy M., Lehner B., Kraus S., Sander P.R., Marschallinger J., Rivera F.J., Trumbach D., Ueberham U., Reitsamer H.A., Strauss O., et al.  TGF-beta signalling in the adult neurogenic niche promotes stem cell quiescence as well as generation of new neurons. J. Cell. Mol. Med. 2014;18:1444–1459. doi: 10.1111/jcmm.12298.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jcmm.12298</ArticleId>
            <ArticleId IdType="pmc">PMC4124027</ArticleId>
            <ArticleId IdType="pubmed">24779367</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meyers E.A., Kessler J.A. TGF-beta Family Signaling in Neural and Neuronal Differentiation, Development, and Function. Cold Spring Harb. Perspect. Biol. 2017;9:a022244. doi: 10.1101/cshperspect.a022244.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/cshperspect.a022244</ArticleId>
            <ArticleId IdType="pmc">PMC5538418</ArticleId>
            <ArticleId IdType="pubmed">28130363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drevets W.C. Neuroplasticity in mood disorders. Dialogues Clin. Neurosci. 2004;6:199–216.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3181795</ArticleId>
            <ArticleId IdType="pubmed">22033747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manji H.K., Moore G.J., Rajkowska G., Chen G. Neuroplasticity and cellular resilience in mood disorders. Mol. Psychiatry. 2000;5:578–593. doi: 10.1038/sj.mp.4000811.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.mp.4000811</ArticleId>
            <ArticleId IdType="pubmed">11126389</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sato S., Sanjo H., Takeda K., Ninomiya-Tsuji J., Yamamoto M., Kawai T., Matsumoto K., Takeuchi O., Akira S. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 2005;6:1087–1095. doi: 10.1038/ni1255.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ni1255</ArticleId>
            <ArticleId IdType="pubmed">16186825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tang M., Wei X., Guo Y., Breslin P., Zhang S., Zhang S., Wei W., Xia Z., Diaz M., Akira S., et al.  TAK1 is required for the survival of hematopoietic cells and hepatocytes in mice. J. Exp. Med. 2008;205:1611–1619. doi: 10.1084/jem.20080297.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.20080297</ArticleId>
            <ArticleId IdType="pmc">PMC2442639</ArticleId>
            <ArticleId IdType="pubmed">18573910</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamaguchi K., Shirakabe K., Shibuya H., Irie K., Oishi I., Ueno N., Taniguchi T., Nishida E., Matsumoto K. Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science. 1995;270:2008–2011. doi: 10.1126/science.270.5244.2008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.270.5244.2008</ArticleId>
            <ArticleId IdType="pubmed">8533096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu J., Zhang F., Wang S., Zhang Y., Fan M., Xu Z. TAK1 is activated by TGF-beta signaling and controls axonal growth during brain development. J. Mol. Cell Biol. 2014;6:349–351. doi: 10.1093/jmcb/mju030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jmcb/mju030</ArticleId>
            <ArticleId IdType="pubmed">24963009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhong J., Li X., McNamee C., Chen A.P., Baccarini M., Snider W.D. Raf kinase signaling functions in sensory neuron differentiation and axon growth in vivo. Nat. Neurosci. 2007;10:598–607. doi: 10.1038/nn1898.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nn1898</ArticleId>
            <ArticleId IdType="pubmed">17396120</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coyle J.T., Duman R.S. Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron. 2003;38:157–160. doi: 10.1016/S0896-6273(03)00195-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0896-6273(03)00195-8</ArticleId>
            <ArticleId IdType="pubmed">12718851</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duman C.H., Schlesinger L., Kodama M., Russell D.S., Duman R.S. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biol. Psychiatry. 2007;61:661–670. doi: 10.1016/j.biopsych.2006.05.047.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biopsych.2006.05.047</ArticleId>
            <ArticleId IdType="pubmed">16945347</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Einat H., Yuan P., Gould T.D., Li J., Du J., Zhang L., Manji H.K., Chen G. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J. Neurosci. 2003;23:7311–7316. doi: 10.1523/JNEUROSCI.23-19-07311.2003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.23-19-07311.2003</ArticleId>
            <ArticleId IdType="pmc">PMC6740453</ArticleId>
            <ArticleId IdType="pubmed">12917364</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wefers B., Hitz C., Holter S.M., Trumbach D., Hansen J., Weber P., Putz B., Deussing J.M., de Angelis M.H., Roenneberg T., et al.  MAPK signaling determines anxiety in the juvenile mouse brain but depression-like behavior in adults. PLoS ONE. 2012;7:e35035.  doi: 10.1371/journal.pone.0035035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0035035</ArticleId>
            <ArticleId IdType="pmc">PMC3329550</ArticleId>
            <ArticleId IdType="pubmed">22529971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lhuillier L., Dryer S.E. Developmental regulation of neuronal KCa channels by TGFbeta 1: Transcriptional and posttranscriptional effects mediated by Erk MAP kinase. J Neurosci. 2000;20:5616–5622. doi: 10.1523/JNEUROSCI.20-15-05616.2000.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.20-15-05616.2000</ArticleId>
            <ArticleId IdType="pmc">PMC6772551</ArticleId>
            <ArticleId IdType="pubmed">10908598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fukushima T., Liu R.Y., Byrne J.H. Transforming growth factor-beta2 modulates synaptic efficacy and plasticity and induces phosphorylation of CREB in hippocampal neurons. Hippocampus. 2007;17:5–9. doi: 10.1002/hipo.20243.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hipo.20243</ArticleId>
            <ArticleId IdType="pubmed">17094084</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Balschun D., Wolfer D.P., Gass P., Mantamadiotis T., Welzl H., Schutz G., Frey J.U., Lipp H.P. Does cAMP response element-binding protein have a pivotal role in hippocampal synaptic plasticity and hippocampus-dependent memory? J. Neurosci. 2003;23:6304–6314. doi: 10.1523/JNEUROSCI.23-15-06304.2003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.23-15-06304.2003</ArticleId>
            <ArticleId IdType="pmc">PMC6740551</ArticleId>
            <ArticleId IdType="pubmed">12867515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nibuya M., Nestler E.J., Duman R.S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci. 1996;16:2365–2372. doi: 10.1523/JNEUROSCI.16-07-02365.1996.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.16-07-02365.1996</ArticleId>
            <ArticleId IdType="pmc">PMC6578518</ArticleId>
            <ArticleId IdType="pubmed">8601816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gur T.L., Conti A.C., Holden J., Bechtholt A.J., Hill T.E., Lucki I., Malberg J.E., Blendy J.A. cAMP response element-binding protein deficiency allows for increased neurogenesis and a rapid onset of antidepressant response. J. Neurosci. 2007;27:7860–7868. doi: 10.1523/JNEUROSCI.2051-07.2007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.2051-07.2007</ArticleId>
            <ArticleId IdType="pmc">PMC6672880</ArticleId>
            <ArticleId IdType="pubmed">17634380</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakagawa S., Kim J.E., Lee R., Chen J., Fujioka T., Malberg J., Tsuji S., Duman R.S. Localization of phosphorylated cAMP response element-binding protein in immature neurons of adult hippocampus. J. Neurosci. 2002;22:9868–9876. doi: 10.1523/JNEUROSCI.22-22-09868.2002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.22-22-09868.2002</ArticleId>
            <ArticleId IdType="pmc">PMC6757843</ArticleId>
            <ArticleId IdType="pubmed">12427843</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakagawa S., Kim J.E., Lee R., Malberg J.E., Chen J., Steffen C., Zhang Y.J., Nestler E.J., Duman R.S. Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein. J. Neurosci. 2002;22:3673–3682. doi: 10.1523/JNEUROSCI.22-09-03673.2002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.22-09-03673.2002</ArticleId>
            <ArticleId IdType="pmc">PMC6758358</ArticleId>
            <ArticleId IdType="pubmed">11978843</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen A.C., Shirayama Y., Shin K.H., Neve R.L., Duman R.S. Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect. Biol. Psychiatry. 2001;49:753–762. doi: 10.1016/S0006-3223(00)01114-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0006-3223(00)01114-8</ArticleId>
            <ArticleId IdType="pubmed">11331083</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dennler S., Goumans M.J., ten Dijke P. Transforming growth factor beta signal transduction. J. Leukoc. Biol. 2002;71:731–740.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11994497</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brown K.A., Pietenpol J.A., Moses H.L. A tale of two proteins: Differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling. J. Cell. Biochem. 2007;101:9–33. doi: 10.1002/jcb.21255.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcb.21255</ArticleId>
            <ArticleId IdType="pubmed">17340614</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bernard D.J. Both SMAD2 and SMAD3 mediate activin-stimulated expression of the follicle-stimulating hormone beta subunit in mouse gonadotrope cells. Mol. Endocrinol. 2004;18:606–623. doi: 10.1210/me.2003-0264.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/me.2003-0264</ArticleId>
            <ArticleId IdType="pubmed">14701940</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Q., Pangas S.A., Jorgez C.J., Graff J.M., Weinstein M., Matzuk M.M. Redundant roles of SMAD2 and SMAD3 in ovarian granulosa cells in vivo. Mol. Cell. Biol. 2008;28:7001–7011. doi: 10.1128/MCB.00732-08.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/MCB.00732-08</ArticleId>
            <ArticleId IdType="pmc">PMC2593383</ArticleId>
            <ArticleId IdType="pubmed">18809571</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brionne T.C., Tesseur I., Masliah E., Wyss-Coray T. Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain. Neuron. 2003;40:1133–1145. doi: 10.1016/S0896-6273(03)00766-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0896-6273(03)00766-9</ArticleId>
            <ArticleId IdType="pubmed">14687548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kulkarni A.B., Huh C.G., Becker D., Geiser A., Lyght M., Flanders K.C., Roberts A.B., Sporn M.B., Ward J.M., Karlsson S. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA. 1993;90:770–774. doi: 10.1073/pnas.90.2.770.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.90.2.770</ArticleId>
            <ArticleId IdType="pmc">PMC45747</ArticleId>
            <ArticleId IdType="pubmed">8421714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miguez D.G., Gil-Guinon E., Pons S., Marti E. Smad2 and Smad3 cooperate and antagonize simultaneously in vertebrate neurogenesis. J. Cell Sci. 2013;126:5335–5343. doi: 10.1242/jcs.130435.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/jcs.130435</ArticleId>
            <ArticleId IdType="pubmed">24105267</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y., Symes A.J. Smad3 deficiency reduces neurogenesis in adult mice. J. Mol. Neurosci. 2010;41:383–396. doi: 10.1007/s12031-010-9329-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12031-010-9329-x</ArticleId>
            <ArticleId IdType="pubmed">20155334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yousef H., Conboy M.J., Morgenthaler A., Schlesinger C., Bugaj L., Paliwal P., Greer C., Conboy I.M., Schaffer D. Systemic attenuation of the TGF-beta pathway by a single drug simultaneously rejuvenates hippocampal neurogenesis and myogenesis in the same old mammal. Oncotarget. 2015;6:11959–11978. doi: 10.18632/oncotarget.3851.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/oncotarget.3851</ArticleId>
            <ArticleId IdType="pmc">PMC4494916</ArticleId>
            <ArticleId IdType="pubmed">26003168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tapia-Gonzalez S., Munoz M.D., Cuartero M.I., Sanchez-Capelo A. Smad3 is required for the survival of proliferative intermediate progenitor cells in the dentate gyrus of adult mice. Cell Commun. Signal. 2013;11:1–15. doi: 10.1186/1478-811X-11-93.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1478-811X-11-93</ArticleId>
            <ArticleId IdType="pmc">PMC4029396</ArticleId>
            <ArticleId IdType="pubmed">24330661</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Munoz M.D., Antolin-Vallespin M., Tapia-Gonzalez S., Sanchez-Capelo A. Smad3 deficiency inhibits dentate gyrus LTP by enhancing GABAA neurotransmission. J. Neurochem. 2016;137:190–199. doi: 10.1111/jnc.13558.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jnc.13558</ArticleId>
            <ArticleId IdType="pubmed">26826552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schmierer B., Tournier A.L., Bates P.A., Hill C.S. Mathematical modeling identifies Smad nucleocytoplasmic shuttling as a dynamic signal-interpreting system. Proc. Natl. Acad. Sci. USA. 2008;105:6608–6613. doi: 10.1073/pnas.0710134105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0710134105</ArticleId>
            <ArticleId IdType="pmc">PMC2373357</ArticleId>
            <ArticleId IdType="pubmed">18443295</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buckwalter M.S., Yamane M., Coleman B.S., Ormerod B.K., Chin J.T., Palmer T., Wyss-Coray T. Chronically increased transforming growth factor-beta1 strongly inhibits hippocampal neurogenesis in aged mice. Am. J. Pathol. 2006;169:154–164. doi: 10.2353/ajpath.2006.051272.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2353/ajpath.2006.051272</ArticleId>
            <ArticleId IdType="pmc">PMC1698757</ArticleId>
            <ArticleId IdType="pubmed">16816369</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He Y., Zhang H., Yung A., Villeda S.A., Jaeger P.A., Olayiwola O., Fainberg N., Wyss-Coray T. ALK5-dependent TGF-beta signaling is a major determinant of late-stage adult neurogenesis. Nat. Neurosci. 2014;17:943–952. doi: 10.1038/nn.3732.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nn.3732</ArticleId>
            <ArticleId IdType="pmc">PMC4096284</ArticleId>
            <ArticleId IdType="pubmed">24859199</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ganea K., Menke A., Schmidt M.V., Lucae S., Rammes G., Liebl C., Harbich D., Sterlemann V., Storch C., Uhr M., et al.  Convergent animal and human evidence suggests the activin/inhibin pathway to be involved in antidepressant response. Transl. Psychiatry. 2012;2:e177. doi: 10.1038/tp.2012.104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/tp.2012.104</ArticleId>
            <ArticleId IdType="pmc">PMC3565812</ArticleId>
            <ArticleId IdType="pubmed">23092981</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shoji-Kasai Y., Ageta H., Hasegawa Y., Tsuchida K., Sugino H., Inokuchi K. Activin increases the number of synaptic contacts and the length of dendritic spine necks by modulating spinal actin dynamics. J. Cell Sci. 2007;120:3830–3837. doi: 10.1242/jcs.012450.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/jcs.012450</ArticleId>
            <ArticleId IdType="pubmed">17940062</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tapia-Gonzalez S., Giraldez-Perez R.M., Cuartero M.I., Casarejos M.J., Mena M.A., Wang X.F., Sanchez-Capelo A. Dopamine and alpha-synuclein dysfunction in Smad3 null mice. Mol. Neurodegener. 2011;6:1–23. doi: 10.1186/1750-1326-6-72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1750-1326-6-72</ArticleId>
            <ArticleId IdType="pmc">PMC3219599</ArticleId>
            <ArticleId IdType="pubmed">21995845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Villapol S., Wang Y., Adams M., Symes A.J. Smad3 deficiency increases cortical and hippocampal neuronal loss following traumatic brain injury. Exp. Neurol. 2013;250:353–365. doi: 10.1016/j.expneurol.2013.10.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.expneurol.2013.10.008</ArticleId>
            <ArticleId IdType="pubmed">24120438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y., Moges H., Bharucha Y., Symes A. Smad3 null mice display more rapid wound closure and reduced scar formation after a stab wound to the cerebral cortex. Exp. Neurol. 2007;203:168–184. doi: 10.1016/j.expneurol.2006.08.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.expneurol.2006.08.006</ArticleId>
            <ArticleId IdType="pubmed">16996058</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma D.K., Jang M.H., Guo J.U., Kitabatake Y., Chang M.L., Pow-Anpongkul N., Flavell R.A., Lu B., Ming G.L., Song H. Neuronal activity-induced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis. Science. 2009;323:1074–1077. doi: 10.1126/science.1166859.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1166859</ArticleId>
            <ArticleId IdType="pmc">PMC2726986</ArticleId>
            <ArticleId IdType="pubmed">19119186</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park D.H., Hong S.J., Salinas R.D., Liu S.J., Sun S.W., Sgualdino J., Testa G., Matzuk M.M., Iwamori N., Lim D.A. Activation of neuronal gene expression by the JMJD3 demethylase is required for postnatal and adult brain neurogenesis. Cell Rep. 2014;8:1290–1299. doi: 10.1016/j.celrep.2014.07.060.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2014.07.060</ArticleId>
            <ArticleId IdType="pmc">PMC4201382</ArticleId>
            <ArticleId IdType="pubmed">25176653</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Estaras C., Akizu N., Garcia A., Beltran S., de la Cruz X., Martinez-Balbas M.A. Genome-wide analysis reveals that Smad3 and JMJD3 HDM co-activate the neural developmental program. Development. 2012;139:2681–2691. doi: 10.1242/dev.078345.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.078345</ArticleId>
            <ArticleId IdType="pubmed">22782721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu C.Y., Gui W., He H.Y., Wang X.S., Zuo J., Huang L., Zhou N., Wang K., Wang Y. Neuronal and astroglial TGFbeta-Smad3 signaling pathways differentially regulate dendrite growth and synaptogenesis. Neuromolecular Med. 2014;16:457–472. doi: 10.1007/s12017-014-8293-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12017-014-8293-y</ArticleId>
            <ArticleId IdType="pubmed">24519742</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Y., Luilkart B.W., Birnbaum S., Chen J., Kwon C.H., Kernie S.G., Bassel-Duby R., Parada L.F. TrkB Regulates Hippocampal Neurogenesis and Governs Sensitivity to Antidepressive Treatment. Neuron. 2008;59:399–412. doi: 10.1016/j.neuron.2008.06.023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuron.2008.06.023</ArticleId>
            <ArticleId IdType="pmc">PMC2655199</ArticleId>
            <ArticleId IdType="pubmed">18701066</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jia S., Ren Z., Li X., Zheng Y., Meng A. Smad2 and Smad3 are required for mesendoderm induction by transforming growth factor-beta/nodal signals in zebrafish. J. Biol. Chem. 2008;283:2418–2426. doi: 10.1074/jbc.M707578200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M707578200</ArticleId>
            <ArticleId IdType="pubmed">18025082</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akizu N., Estaras C., Guerrero L., Marti E., Martinez-Balbas M.A. H3K27me3 regulates BMP activity in developing spinal cord. Development. 2010;137:2915–2925. doi: 10.1242/dev.049395.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.049395</ArticleId>
            <ArticleId IdType="pubmed">20667911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iida A., Iwagawa T., Kuribayashi H., Satoh S., Mochizuki Y., Baba Y., Nakauchi H., Furukawa T., Koseki H., Murakami A., et al.  Histone demethylase Jmjd3 is required for the development of subsets of retinal bipolar cells. Proc. Natl. Acad. Sci. USA. 2014;111:3751–3756. doi: 10.1073/pnas.1311480111.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1311480111</ArticleId>
            <ArticleId IdType="pmc">PMC3956141</ArticleId>
            <ArticleId IdType="pubmed">24572572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grassi D., Franz H., Vezzali R., Bovio P., Heidrich S., Dehghanian F., Lagunas N., Belzung C., Krieglstein K., Vogel T. Neuronal Activity, TGFbeta-Signaling and Unpredictable Chronic Stress Modulate Transcription of Gadd45 Family Members and DNA Methylation in the Hippocampus. Cereb. Cortex. 2017;27:4166–4181. doi: 10.1093/cercor/bhx095.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cercor/bhx095</ArticleId>
            <ArticleId IdType="pubmed">28444170</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malberg J.E., Eisch A.J., Nestler E.J., Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 2000;20:9104–9110. doi: 10.1523/JNEUROSCI.20-24-09104.2000.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.20-24-09104.2000</ArticleId>
            <ArticleId IdType="pmc">PMC6773038</ArticleId>
            <ArticleId IdType="pubmed">11124987</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jayatissa M.N., Henningsen K., Nikolajsen G., West M.J., Wiborg O. A reduced number of hippocampal granule cells does not associate with an anhedonia-like phenotype in a rat chronic mild stress model of depression. Stress. 2010;13:95–105. doi: 10.3109/10253890902951786.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/10253890902951786</ArticleId>
            <ArticleId IdType="pubmed">19929309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lagace D.C., Donovan M.H., DeCarolis N.A., Farnbauch L.A., Malhotra S., Berton O., Nestler E.J., Krishnan V., Eisch A.J. Adult hippocampal neurogenesis is functionally important for stress-induced social avoidance. Proc. Natl. Acad. Sci. USA. 2010;107:4436–4441. doi: 10.1073/pnas.0910072107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0910072107</ArticleId>
            <ArticleId IdType="pmc">PMC2840117</ArticleId>
            <ArticleId IdType="pubmed">20176946</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eisch A.J., Petrik D. Depression and hippocampal neurogenesis: A road to remission? Science. 2012;338:72–75. doi: 10.1126/science.1222941.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1222941</ArticleId>
            <ArticleId IdType="pmc">PMC3756889</ArticleId>
            <ArticleId IdType="pubmed">23042885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lyons D.M., Buckmaster P.S., Lee A.G., Wu C., Mitra R., Duffey L.M., Buckmaster C.L., Her S., Patel P.D., Schatzberg A.F. Stress coping stimulates hippocampal neurogenesis in adult monkeys. Proc. Natl. Acad. Sci. USA. 2010;107:14823–14827. doi: 10.1073/pnas.0914568107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0914568107</ArticleId>
            <ArticleId IdType="pmc">PMC2930418</ArticleId>
            <ArticleId IdType="pubmed">20675584</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parihar V.K., Hattiangady B., Kuruba R., Shuai B., Shetty A.K. Predictable chronic mild stress improves mood, hippocampal neurogenesis and memory. Mol. Psychiatry. 2011;16:171–183. doi: 10.1038/mp.2009.130.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/mp.2009.130</ArticleId>
            <ArticleId IdType="pmc">PMC2891880</ArticleId>
            <ArticleId IdType="pubmed">20010892</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petrik D., Lagace D.C., Eisch A.J. The neurogenesis hypothesis of affective and anxiety disorders: Are we mistaking the scaffolding for the building? Neuropharmacology. 2012;62:21–34. doi: 10.1016/j.neuropharm.2011.09.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuropharm.2011.09.003</ArticleId>
            <ArticleId IdType="pmc">PMC3698048</ArticleId>
            <ArticleId IdType="pubmed">21945290</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., McClay J., Mill J., Martin J., Braithwaite A., et al.  Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386–389. doi: 10.1126/science.1083968.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1083968</ArticleId>
            <ArticleId IdType="pubmed">12869766</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heuser I. Anna-Monika-Prize paper. The hypothalamic-pituitary-adrenal system in depression. Pharmacopsychiatry. 1998;31:10–13. doi: 10.1055/s-2007-979288.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-2007-979288</ArticleId>
            <ArticleId IdType="pubmed">9524978</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mizoguchi K., Ishige A., Aburada M., Tabira T. Chronic stress attenuates glucocorticoid negative feedback: Involvement of the prefrontal cortex and hippocampus. Neuroscience. 2003;119:887–897. doi: 10.1016/S0306-4522(03)00105-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0306-4522(03)00105-2</ArticleId>
            <ArticleId IdType="pubmed">12809708</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Herman J.P., Spencer R. Regulation of hippocampal glucocorticoid receptor gene transcription and protein expression in vivo. J. Neurosci. 1998;18:7462–7473. doi: 10.1523/JNEUROSCI.18-18-07462.1998.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.18-18-07462.1998</ArticleId>
            <ArticleId IdType="pmc">PMC6793224</ArticleId>
            <ArticleId IdType="pubmed">9736665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gould E., McEwen B.S., Tanapat P., Galea L.A., Fuchs E. Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation. J. Neurosci. 1997;17:2492–2498. doi: 10.1523/JNEUROSCI.17-07-02492.1997.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.17-07-02492.1997</ArticleId>
            <ArticleId IdType="pmc">PMC6573503</ArticleId>
            <ArticleId IdType="pubmed">9065509</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malberg J.E., Duman R.S. Cell proliferation in adult hippocampus is decreased by inescapable stress: Reversal by fluoxetine treatment. Neuropsychopharmacology. 2003;28:1562–1571. doi: 10.1038/sj.npp.1300234.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.npp.1300234</ArticleId>
            <ArticleId IdType="pubmed">12838272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pham K., Nacher J., Hof P.R., McEwen B.S. Repeated restraint stress suppresses neurogenesis and induces biphasic PSA-NCAM expression in the adult rat dentate gyrus. Eur. J. Neurosci. 2003;17:879–886. doi: 10.1046/j.1460-9568.2003.02513.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1460-9568.2003.02513.x</ArticleId>
            <ArticleId IdType="pubmed">12603278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>You Z., Luo C., Zhang W., Chen Y., He J., Zhao Q., Zuo R., Wu Y. Pro- and anti-inflammatory cytokines expression in rat’s brain and spleen exposed to chronic mild stress: Involvement in depression. Behav. Brain Res. 2011;225:135–141. doi: 10.1016/j.bbr.2011.07.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbr.2011.07.006</ArticleId>
            <ArticleId IdType="pubmed">21767575</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anacker C., Cattaneo A., Luoni A., Musaelyan K., Zunszain P.A., Milanesi E., Rybka J., Berry A., Cirulli F., Thuret S., et al.  Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis. Neuropsychopharmacology. 2013;38:872–883. doi: 10.1038/npp.2012.253.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/npp.2012.253</ArticleId>
            <ArticleId IdType="pmc">PMC3672002</ArticleId>
            <ArticleId IdType="pubmed">23303060</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bremner J.D., Elzinga B., Schmahl C., Vermetten E. Structural and functional plasticity of the human brain in posttraumatic stress disorder. Prog. Brain Res. 2008;167:171–186. doi: 10.1016/S0079-6123(07)67012-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0079-6123(07)67012-5</ArticleId>
            <ArticleId IdType="pmc">PMC3226705</ArticleId>
            <ArticleId IdType="pubmed">18037014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gould E., Cameron H.A., Daniels D.C., Woolley C.S., McEwen B.S. Adrenal hormones suppress cell division in the adult rat dentate gyrus. J. Neurosci. 1992;12:3642–3650. doi: 10.1523/JNEUROSCI.12-09-03642.1992.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.12-09-03642.1992</ArticleId>
            <ArticleId IdType="pmc">PMC6575731</ArticleId>
            <ArticleId IdType="pubmed">1527603</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jacobs B.L., van Praag H., Gage F.H. Adult brain neurogenesis and psychiatry: A novel theory of depression. Mol. Psychiatry. 2000;5:262–269. doi: 10.1038/sj.mp.4000712.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.mp.4000712</ArticleId>
            <ArticleId IdType="pubmed">10889528</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakashiba T., Cushman J.D., Pelkey K.A., Renaudineau S., Buhl D.L., McHugh T.J., Rodriguez Barrera V., Chittajallu R., Iwamoto K.S., McBain C.J., et al.  Young dentate granule cells mediate pattern separation, whereas old granule cells facilitate pattern completion. Cell. 2012;149:188–201. doi: 10.1016/j.cell.2012.01.046.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2012.01.046</ArticleId>
            <ArticleId IdType="pmc">PMC3319279</ArticleId>
            <ArticleId IdType="pubmed">22365813</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anacker C., Pariante C.M. Can adult neurogenesis buffer stress responses and depressive behaviour? Mol. Psychiatry. 2012;17:9–10. doi: 10.1038/mp.2011.133.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/mp.2011.133</ArticleId>
            <ArticleId IdType="pubmed">21986876</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hill M.N., Patel S. Translational evidence for the involvement of the endocannabinoid system in stress-related psychiatric illnesses. Biol. Mood Anxiety Disord. 2013;3:1–14. doi: 10.1186/2045-5380-3-19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/2045-5380-3-19</ArticleId>
            <ArticleId IdType="pmc">PMC3817535</ArticleId>
            <ArticleId IdType="pubmed">24286185</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qin Z., Zhou X., Pandey N.R., Vecchiarelli H.A., Stewart C.A., Zhang X., Lagace D.C., Brunel J.M., Beique J.C., Stewart A.F., et al.  Chronic stress induces anxiety via an amygdalar intracellular cascade that impairs endocannabinoid signaling. Neuron. 2015;85:1319–1331. doi: 10.1016/j.neuron.2015.02.015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuron.2015.02.015</ArticleId>
            <ArticleId IdType="pubmed">25754825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bremner J.D., Narayan M., Anderson E.R., Staib L.H., Miller H.L., Charney D.S. Hippocampal volume reduction in major depression. Am. J. Psychiatry. 2000;157:115–118. doi: 10.1176/ajp.157.1.115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1176/ajp.157.1.115</ArticleId>
            <ArticleId IdType="pubmed">10618023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>MacQueen G.M., Campbell S., McEwen B.S., Macdonald K., Amano S., Joffe R.T., Nahmias C., Young L.T. Course of illness, hippocampal function, and hippocampal volume in major depression. Proc. Natl. Acad. Sci. USA. 2003;100:1387–1392. doi: 10.1073/pnas.0337481100.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0337481100</ArticleId>
            <ArticleId IdType="pmc">PMC298782</ArticleId>
            <ArticleId IdType="pubmed">12552118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. USA. 1996;93:3908–3913. doi: 10.1073/pnas.93.9.3908.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.93.9.3908</ArticleId>
            <ArticleId IdType="pmc">PMC39458</ArticleId>
            <ArticleId IdType="pubmed">8632988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang X.W., Yu Y., Gu L. Dehydroabietic acid reverses TNF-alpha-induced the activation of FOXO1 and suppression of TGF-beta1/Smad signaling in human adult dermal fibroblasts. Int. J. Clin. Exp. Pathol. 2014;7:8616–8626.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4314026</ArticleId>
            <ArticleId IdType="pubmed">25674226</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cattaneo A., Cattane N., Malpighi C., Czamara D., Suarez A., Mariani N., Kajantie E., Luoni A., Eriksson J.G., Lahti J., et al.  FoxO1, A2M, and TGF-beta1: Three novel genes predicting depression in gene X environment interactions are identified using cross-species and cross-tissues transcriptomic and miRNomic analyses. Mol. Psychiatry. 2018;23:2192–2208. doi: 10.1038/s41380-017-0002-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41380-017-0002-4</ArticleId>
            <ArticleId IdType="pmc">PMC6283860</ArticleId>
            <ArticleId IdType="pubmed">29302075</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Etkin A., Prater K.E., Schatzberg A.F., Menon V., Greicius M.D. Disrupted amygdalar subregion functional connectivity and evidence of a compensatory network in generalized anxiety disorder. Arch. Gen. Psychiatry. 2009;66:1361–1372. doi: 10.1001/archgenpsychiatry.2009.104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archgenpsychiatry.2009.104</ArticleId>
            <ArticleId IdType="pubmed">19996041</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim M.J., Loucks R.A., Palmer A.L., Brown A.C., Solomon K.M., Marchante A.N., Whalen P.J. The structural and functional connectivity of the amygdala: From normal emotion to pathological anxiety. Behav. Brain Res. 2011;223:403–410. doi: 10.1016/j.bbr.2011.04.025.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbr.2011.04.025</ArticleId>
            <ArticleId IdType="pmc">PMC3119771</ArticleId>
            <ArticleId IdType="pubmed">21536077</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patel S., Roelke C.T., Rademacher D.J., Cullinan W.E., Hillard C.J. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology. 2004;145:5431–5438. doi: 10.1210/en.2004-0638.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/en.2004-0638</ArticleId>
            <ArticleId IdType="pubmed">15331569</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shonesy B.C., Bluett R.J., Ramikie T.S., Baldi R., Hermanson D.J., Kingsley P.J., Marnett L.J., Winder D.G., Colbran R.J., Patel S. Genetic disruption of 2-arachidonoylglycerol synthesis reveals a key role for endocannabinoid signaling in anxiety modulation. Cell Rep. 2014;9:1644–1653. doi: 10.1016/j.celrep.2014.11.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2014.11.001</ArticleId>
            <ArticleId IdType="pmc">PMC4268380</ArticleId>
            <ArticleId IdType="pubmed">25466252</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gunduz-Cinar O., Hill M.N., McEwen B.S., Holmes A. Amygdala FAAH and anandamide: Mediating protection and recovery from stress. Trends Pharmacol. Sci. 2013;34:637–644. doi: 10.1016/j.tips.2013.08.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tips.2013.08.008</ArticleId>
            <ArticleId IdType="pmc">PMC4169112</ArticleId>
            <ArticleId IdType="pubmed">24325918</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cambien F., Ricard S., Troesch A., Mallet C., Generenaz L., Evans A., Arveiler D., Luc G., Ruidavets J.B., Poirier O. Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de l’Infarctus du Myocarde (ECTIM) Study. Hypertension. 1996;28:881–887. doi: 10.1161/01.HYP.28.5.881.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.HYP.28.5.881</ArticleId>
            <ArticleId IdType="pubmed">8901839</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jin G., Deng Y., Miao R., Hu Z., Zhou Y., Tan Y., Wang J., Hua Z., Ding W., Wang L., et al.  TGFB1 and TGFBR2 functional polymorphisms and risk of esophageal squamous cell carcinoma: A case-control analysis in a Chinese population. J. Cancer Res. Clin. Oncol. 2008;134:345–351. doi: 10.1007/s00432-007-0290-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00432-007-0290-1</ArticleId>
            <ArticleId IdType="pubmed">17680270</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim S.H., Lee S.H., Choi Y.L., Wang L.H., Park C.K., Shin Y.K. Extensive alteration in the expression profiles of TGFB pathway signaling components and TP53 is observed along the gastric dysplasia-carcinoma sequence. Histol. Histopathol. 2008;23:1439–1452. doi: 10.14670/HH-23.1439.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.14670/HH-23.1439</ArticleId>
            <ArticleId IdType="pubmed">18830930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yan C., Yang Q., Gong Z. Transgenic expression of tgfb1a induces hepatic inflammation, fibrosis and metastasis in zebrafish. Biochem. Biophys. Res. Commun. 2019;509:175–181. doi: 10.1016/j.bbrc.2018.12.098.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2018.12.098</ArticleId>
            <ArticleId IdType="pubmed">30581008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elliott R.L., Blobe G.C. Role of transforming growth factor Beta in human cancer. J. Clin. Oncol. 2005;23:2078–2093. doi: 10.1200/JCO.2005.02.047.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1200/JCO.2005.02.047</ArticleId>
            <ArticleId IdType="pubmed">15774796</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hata A., Shi Y., Massague J. TGF-beta signaling and cancer: Structural and functional consequences of mutations in Smads. Mol. Med. Today. 1998;4:257–262. doi: 10.1016/S1357-4310(98)01247-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1357-4310(98)01247-7</ArticleId>
            <ArticleId IdType="pubmed">9679244</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jahn S.C., Law M.E., Corsino P.E., Law B.K. TGF-beta antiproliferative effects in tumor suppression. Front. Biosci. (Schol. Ed.) 2012;4:749–766. doi: 10.2741/s297.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2741/s297</ArticleId>
            <ArticleId IdType="pubmed">22202088</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Han S.U., Kim H.T., Seong D.H., Kim Y.S., Park Y.S., Bang Y.J., Yang H.K., Kim S.J. Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer. Oncogene. 2004;23:1333–1341. doi: 10.1038/sj.onc.1207259.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.onc.1207259</ArticleId>
            <ArticleId IdType="pubmed">14647420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boulanger C.A., Smith G.H. Reducing mammary cancer risk through premature stem cell senescence. Oncogene. 2001;20:2264–2272. doi: 10.1038/sj.onc.1204312.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.onc.1204312</ArticleId>
            <ArticleId IdType="pubmed">11402321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pierce D.F., Jr., Gorska A.E., Chytil A., Meise K.S., Page D.L., Coffey R.J., Jr., Moses H.L. Mammary tumor suppression by transforming growth factor beta 1 transgene expression. Proc. Natl. Acad. Sci. USA. 1995;92:4254–4258. doi: 10.1073/pnas.92.10.4254.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.92.10.4254</ArticleId>
            <ArticleId IdType="pmc">PMC41922</ArticleId>
            <ArticleId IdType="pubmed">7753792</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Siegel P.M., Shu W., Cardiff R.D., Muller W.J., Massague J. Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proc. Natl. Acad. Sci. USA. 2003;100:8430–8435. doi: 10.1073/pnas.0932636100.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0932636100</ArticleId>
            <ArticleId IdType="pmc">PMC166246</ArticleId>
            <ArticleId IdType="pubmed">12808151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buckwalter M.S., Wyss-Coray T. Modelling neuroinflammatory phenotypes in vivo. J. Neuroinflamm. 2004;1:1–12. doi: 10.1186/1742-2094-1-10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1742-2094-1-10</ArticleId>
            <ArticleId IdType="pmc">PMC500895</ArticleId>
            <ArticleId IdType="pubmed">15285805</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finch C.E., Laping N.J., Morgan T.E., Nichols N.R., Pasinetti G.M. TGF-beta 1 is an organizer of responses to neurodegeneration. J. Cell. Biochem. 1993;53:314–322. doi: 10.1002/jcb.240530408.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcb.240530408</ArticleId>
            <ArticleId IdType="pubmed">8300749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Brien M.F., Lenke L.G., Lou J., Bridwell K.H., Joyce M.E. Astrocyte response and transforming growth factor-beta localization in acute spinal cord injury. Spine. 1994;19:2321–2329. doi: 10.1097/00007632-199410150-00012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00007632-199410150-00012</ArticleId>
            <ArticleId IdType="pubmed">7846578</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buss A., Pech K., Kakulas B.A., Martin D., Schoenen J., Noth J., Brook G.A. TGF-beta1 and TGF-beta2 expression after traumatic human spinal cord injury. Spinal Cord. 2008;46:364–371. doi: 10.1038/sj.sc.3102148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.sc.3102148</ArticleId>
            <ArticleId IdType="pubmed">18040277</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nicoletti F., Di Marco R., Patti F., Reggio E., Nicoletti A., Zaccone P., Stivala F., Meroni P.L., Reggio A. Blood levels of transforming growth factor-beta 1 (TGF-beta1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-beta1b) Clin. Exp. Immunol. 1998;113:96–99. doi: 10.1046/j.1365-2249.1998.00604.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1365-2249.1998.00604.x</ArticleId>
            <ArticleId IdType="pmc">PMC1905006</ArticleId>
            <ArticleId IdType="pubmed">9697990</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Estrada L.D., Oliveira-Cruz L., Cabrera D. Transforming Growth Factor Beta Type I Role in Neurodegeneration: Implications for Alzheimer s Disease. Curr. Protein Pept. Sci. 2018;19:1180–1188. doi: 10.2174/1389203719666171129094937.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/1389203719666171129094937</ArticleId>
            <ArticleId IdType="pubmed">29189146</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chao C.C., Hu S., Frey W.H., 2nd, Ala T.A., Tourtellotte W.W., Peterson P.K. Transforming growth factor beta in Alzheimer’s disease. Clin. Diagn. Lab. Immunol. 1994;1:109–110. doi: 10.1128/CDLI.1.1.109-110.1994.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CDLI.1.1.109-110.1994</ArticleId>
            <ArticleId IdType="pmc">PMC368205</ArticleId>
            <ArticleId IdType="pubmed">7496909</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vawter M.P., Dillon-Carter O., Tourtellotte W.W., Carvey P., Freed W.J. TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson’s disease in ventricular cerebrospinal fluid. Exp. Neurol. 1996;142:313–322. doi: 10.1006/exnr.1996.0200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/exnr.1996.0200</ArticleId>
            <ArticleId IdType="pubmed">8934562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saunier E.F., Akhurst R.J. TGF beta inhibition for cancer therapy. Curr. Cancer Drug Targets. 2006;6:565–578. doi: 10.2174/156800906778742460.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/156800906778742460</ArticleId>
            <ArticleId IdType="pubmed">17100564</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prud’homme G.J. Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations. Lab. Investig. 2007;87:1077–1091. doi: 10.1038/labinvest.3700669.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/labinvest.3700669</ArticleId>
            <ArticleId IdType="pubmed">17724448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruzek M.C., Hawes M., Pratt B., McPherson J., Ledbetter S., Richards S.M., Garman R.D. Minimal effects on immune parameters following chronic anti-TGF-beta monoclonal antibody administration to normal mice. Immunopharmacol. Immunotoxicol. 2003;25:235–257. doi: 10.1081/IPH-120020473.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1081/IPH-120020473</ArticleId>
            <ArticleId IdType="pubmed">12784916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang Y.A., Dukhanina O., Tang B., Mamura M., Letterio J.J., MacGregor J., Patel S.C., Khozin S., Liu Z.Y., Green J., et al.  Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects. J. Clin. Investig. 2002;109:1607–1615. doi: 10.1172/JCI200215333.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI200215333</ArticleId>
            <ArticleId IdType="pmc">PMC151015</ArticleId>
            <ArticleId IdType="pubmed">12070308</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Forrester E., Chytil A., Bierie B., Aakre M., Gorska A.E., Sharif-Afshar A.R., Muller W.J., Moses H.L. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis. Cancer Res. 2005;65:2296–2302. doi: 10.1158/0008-5472.CAN-04-3272.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-04-3272</ArticleId>
            <ArticleId IdType="pubmed">15781643</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wyss-Coray T. Tgf-Beta pathway as a potential target in neurodegeneration and Alzheimer’s. Curr. Alzheimer Res. 2006;3:191–195. doi: 10.2174/156720506777632916.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/156720506777632916</ArticleId>
            <ArticleId IdType="pubmed">16842094</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sahay A., Drew M.R., Hen R. Dentate gyrus neurogenesis and depression. Prog. Brain Res. 2007;163:697–722. doi: 10.1016/S0079-6123(07)63038-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0079-6123(07)63038-6</ArticleId>
            <ArticleId IdType="pubmed">17765746</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sahay A., Hen R. Adult hippocampal neurogenesis in depression. Nat. Neurosci. 2007;10:1110–1115. doi: 10.1038/nn1969.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nn1969</ArticleId>
            <ArticleId IdType="pubmed">17726477</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vollmayr B., Mahlstedt M.M., Henn F.A. Neurogenesis and depression: What animal models tell us about the link. Eur. Arch. Psychiatry Clin. Neurosci. 2007;257:300–303. doi: 10.1007/s00406-007-0734-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00406-007-0734-2</ArticleId>
            <ArticleId IdType="pubmed">17401725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gold P.W., Goodwin F.K., Chrousos G.P. Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2) N. Engl. J. Med. 1988;319:413–420. doi: 10.1056/NEJM198808183190706.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJM198808183190706</ArticleId>
            <ArticleId IdType="pubmed">3041279</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sapolsky R.M. The possibility of neurotoxicity in the hippocampus in major depression: A primer on neuron death. Biol. Psychiatry. 2000;48:755–765. doi: 10.1016/S0006-3223(00)00971-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0006-3223(00)00971-9</ArticleId>
            <ArticleId IdType="pubmed">11063972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davidson R.J., Lewis D.A., Alloy L.B., Amaral D.G., Bush G., Cohen J.D., Drevets W.C., Farah M.J., Kagan J., McClelland J.L., et al.  Neural and behavioral substrates of mood and mood regulation. Biol. Psychiatry. 2002;52:478–502. doi: 10.1016/S0006-3223(02)01458-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0006-3223(02)01458-0</ArticleId>
            <ArticleId IdType="pubmed">12361665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Czeh B., Michaelis T., Watanabe T., Frahm J., de Biurrun G., van Kampen M., Bartolomucci A., Fuchs E. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc. Natl. Acad. Sci. USA. 2001;98:12796–12801. doi: 10.1073/pnas.211427898.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.211427898</ArticleId>
            <ArticleId IdType="pmc">PMC60133</ArticleId>
            <ArticleId IdType="pubmed">11675510</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anacker C., Zunszain P.A., Cattaneo A., Carvalho L.A., Garabedian M.J., Thuret S., Price J., Pariante C.M. Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor. Mol. Psychiatry. 2011;16:738–750. doi: 10.1038/mp.2011.26.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/mp.2011.26</ArticleId>
            <ArticleId IdType="pmc">PMC3121947</ArticleId>
            <ArticleId IdType="pubmed">21483429</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perera T.D., Coplan J.D., Lisanby S.H., Lipira C.M., Arif M., Carpio C., Spitzer G., Santarelli L., Scharf B., Hen R., et al.  Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates. J. Neurosci. 2007;27:4894–4901. doi: 10.1523/JNEUROSCI.0237-07.2007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.0237-07.2007</ArticleId>
            <ArticleId IdType="pmc">PMC6672102</ArticleId>
            <ArticleId IdType="pubmed">17475797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., Weisstaub N., Lee J., Duman R., Arancio O., et al.  Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science. 2003;301:805–809. doi: 10.1126/science.1083328.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1083328</ArticleId>
            <ArticleId IdType="pubmed">12907793</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vollmayr B., Simonis C., Weber S., Gass P., Henn F. Reduced cell proliferation in the dentate gyrus is not correlated with the development of learned helplessness. Biol. Psychiatry. 2003;54:1035–1040. doi: 10.1016/S0006-3223(03)00527-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0006-3223(03)00527-4</ArticleId>
            <ArticleId IdType="pubmed">14625145</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Czeh B., Welt T., Fischer A.K., Erhardt A., Schmitt W., Muller M.B., Toschi N., Fuchs E., Keck M.E. Chronic psychosocial stress and concomitant repetitive transcranial magnetic stimulation: Effects on stress hormone levels and adult hippocampal neurogenesis. Biol. Psychiatry. 2002;52:1057–1065. doi: 10.1016/S0006-3223(02)01457-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0006-3223(02)01457-9</ArticleId>
            <ArticleId IdType="pubmed">12460689</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee K.J., Kim S.J., Kim S.W., Choi S.H., Shin Y.C., Park S.H., Moon B.H., Cho E., Lee M.S., Choi S.H., et al.  Chronic mild stress decreases survival, but not proliferation, of new-born cells in adult rat hippocampus. Exp. Mol. Med. 2006;38:44–54. doi: 10.1038/emm.2006.6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/emm.2006.6</ArticleId>
            <ArticleId IdType="pubmed">16520552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bennett A.J., Lesch K.P., Heils A., Long J.C., Lorenz J.G., Shoaf S.E., Champoux M., Suomi S.J., Linnoila M.V., Higley J.D. Early experience and serotonin transporter gene variation interact to influence primate CNS function. Mol. Psychiatry. 2002;7:118–122. doi: 10.1038/sj.mp.4000949.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.mp.4000949</ArticleId>
            <ArticleId IdType="pubmed">11803458</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coe C.L., Kramer M., Czeh B., Gould E., Reeves A.J., Kirschbaum C., Fuchs E. Prenatal stress diminishes neurogenesis in the dentate gyrus of juvenile rhesus monkeys. Biol. Psychiatry. 2003;54:1025–1034. doi: 10.1016/S0006-3223(03)00698-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0006-3223(03)00698-X</ArticleId>
            <ArticleId IdType="pubmed">14625144</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaufman J., Yang B.Z., Douglas-Palumberi H., Grasso D., Lipschitz D., Houshyar S., Krystal J.H., Gelernter J. Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol. Psychiatry. 2006;59:673–680. doi: 10.1016/j.biopsych.2005.10.026.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biopsych.2005.10.026</ArticleId>
            <ArticleId IdType="pubmed">16458264</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spalding K.L., Bergmann O., Alkass K., Bernard S., Salehpour M., Huttner H.B., Bostrom E., Westerlund I., Vial C., Buchholz B.A., et al.  Dynamics of hippocampal neurogenesis in adult humans. Cell. 2013;153:1219–1227. doi: 10.1016/j.cell.2013.05.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2013.05.002</ArticleId>
            <ArticleId IdType="pmc">PMC4394608</ArticleId>
            <ArticleId IdType="pubmed">23746839</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boldrini M., Fulmore C.A., Tartt A.N., Simeon L.R., Pavlova I., Poposka V., Rosoklija G.B., Stankov A., Arango V., Dwork A.J., et al.  Human Hippocampal Neurogenesis Persists throughout Aging. Cell Stem Cell. 2018;22:589–599.e585. doi: 10.1016/j.stem.2018.03.015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.stem.2018.03.015</ArticleId>
            <ArticleId IdType="pmc">PMC5957089</ArticleId>
            <ArticleId IdType="pubmed">29625071</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Toda T., Parylak S.L., Linker S.B., Gage F.H. The role of adult hippocampal neurogenesis in brain health and disease. Mol. Psychiatry. 2019;24:67–87. doi: 10.1038/s41380-018-0036-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41380-018-0036-2</ArticleId>
            <ArticleId IdType="pmc">PMC6195869</ArticleId>
            <ArticleId IdType="pubmed">29679070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Snyder J.S., Soumier A., Brewer M., Pickel J., Cameron H.A. Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature. 2011;476:458–461. doi: 10.1038/nature10287.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature10287</ArticleId>
            <ArticleId IdType="pmc">PMC3162077</ArticleId>
            <ArticleId IdType="pubmed">21814201</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jung S., Choe S., Woo H., Jeong H., An H.K., Moon H., Ryu H.Y., Yeo B.K., Lee Y.W., Choi H., et al.  Autophagic death of neural stem cells mediates chronic stress-induced decline of adult hippocampal neurogenesis and cognitive deficits. Autophagy. 2020;16:512–530. doi: 10.1080/15548627.2019.1630222.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/15548627.2019.1630222</ArticleId>
            <ArticleId IdType="pmc">PMC6999625</ArticleId>
            <ArticleId IdType="pubmed">31234698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neumeister A., Wood S., Bonne O., Nugent A.C., Luckenbaugh D.A., Young T., Bain E.E., Charney D.S., Drevets W.C. Reduced hippocampal volume in unmedicated, remitted patients with major depression versus control subjects. Biol. Psychiatry. 2005;57:935–937. doi: 10.1016/j.biopsych.2005.01.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biopsych.2005.01.016</ArticleId>
            <ArticleId IdType="pubmed">15820716</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sivakumar P.T., Kalmady S.V., Venkatasubramanian G., Bharath S., Reddy N.N., Rao N.P., Kovoor J.M., Jain S., Varghese M. Volumetric analysis of hippocampal sub-regions in late onset depression: A 3 tesla magnetic resonance imaging study. Asian J. Psychiatry. 2015;13:38–43. doi: 10.1016/j.ajp.2014.11.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajp.2014.11.005</ArticleId>
            <ArticleId IdType="pubmed">25524757</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pinto V., Costa J.C., Morgado P., Mota C., Miranda A., Bravo F.V., Oliveira T.G., Cerqueira J.J., Sousa N. Differential impact of chronic stress along the hippocampal dorsal-ventral axis. Brain Struct. Funct. 2015;220:1205–1212. doi: 10.1007/s00429-014-0713-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00429-014-0713-0</ArticleId>
            <ArticleId IdType="pubmed">24500370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahima R.S., Harlan R.E. Charting of type II glucocorticoid receptor-like immunoreactivity in the rat central nervous system. Neuroscience. 1990;39:579–604. doi: 10.1016/0306-4522(90)90244-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0306-4522(90)90244-X</ArticleId>
            <ArticleId IdType="pubmed">1711170</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aggleton J.P. A description of the amygdalo-hippocampal interconnections in the macaque monkey. Exp. Brain Res. 1986;64:515–526. doi: 10.1007/BF00340489.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF00340489</ArticleId>
            <ArticleId IdType="pubmed">3803489</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pikkarainen M., Ronkko S., Savander V., Insausti R., Pitkanen A. Projections from the lateral, basal, and accessory basal nuclei of the amygdala to the hippocampal formation in rat. J. Comp. Neurol. 1999;403:229–260. doi: 10.1002/(SICI)1096-9861(19990111)403:2&lt;229::AID-CNE7&gt;3.0.CO;2-P.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1096-9861(19990111)403:2&lt;229::AID-CNE7&gt;3.0.CO;2-P</ArticleId>
            <ArticleId IdType="pubmed">9886046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Czeh B., Simon M., Schmelting B., Hiemke C., Fuchs E. Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment. Neuropsychopharmacology. 2006;31:1616–1626. doi: 10.1038/sj.npp.1300982.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.npp.1300982</ArticleId>
            <ArticleId IdType="pubmed">16395301</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Czeh B., Varga Z.K., Henningsen K., Kovacs G.L., Miseta A., Wiborg O. Chronic stress reduces the number of GABAergic interneurons in the adult rat hippocampus, dorsal-ventral and region-specific differences. Hippocampus. 2015;25:393–405. doi: 10.1002/hipo.22382.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hipo.22382</ArticleId>
            <ArticleId IdType="pubmed">25331166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cobb J.A., O’Neill K., Milner J., Mahajan G.J., Lawrence T.J., May W.L., Miguel-Hidalgo J., Rajkowska G., Stockmeier C.A. Density of GFAP-immunoreactive astrocytes is decreased in left hippocampi in major depressive disorder. Neuroscience. 2016;316:209–220. doi: 10.1016/j.neuroscience.2015.12.044.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuroscience.2015.12.044</ArticleId>
            <ArticleId IdType="pmc">PMC4836620</ArticleId>
            <ArticleId IdType="pubmed">26742791</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Czeh B., Abumaria N., Rygula R., Fuchs E. Quantitative changes in hippocampal microvasculature of chronically stressed rats: No effect of fluoxetine treatment. Hippocampus. 2010;20:174–185. doi: 10.1002/hipo.20599.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hipo.20599</ArticleId>
            <ArticleId IdType="pubmed">19330847</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rajkowska G., Stockmeier C.A. Astrocyte pathology in major depressive disorder: Insights from human postmortem brain tissue. Curr. Drug Targets. 2013;14:1225–1236. doi: 10.2174/13894501113149990156.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/13894501113149990156</ArticleId>
            <ArticleId IdType="pmc">PMC3799810</ArticleId>
            <ArticleId IdType="pubmed">23469922</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
